A biological solution for localized cartilage lesions
Articular cartilage is a fundamental structure for the proper functioning of our joints. Thin, smooth, and avascular, it allows bones to glide smoothly against each other without friction and cushions the impact of every movement. When damaged—whether due to trauma, premature wear, or mechanical overload—it can cause chronic pain, stiffness, or difficulty walking. Unlike other tissues in the body, cartilage does not regenerate naturally. It is in this context that... ChondroFiller®, an innovative biomaterial, offers a targeted therapeutic option for repairing cartilage loss without resorting to a prosthesis, particularly in young or active patients.
Restoring cartilage without replacing it: why it's possible
Until recently, articular cartilage lesions had few surgical alternatives besides microfracture or joint replacement. The solutions were either too invasive or not very long-lasting. However, many people suffer from joint pain related to cartilage damage. focal lengths, That is to say, limited to a small area of the joint, without generalized osteoarthritis. These lesions can occur in athletes, after a knee injury, or simply in active people whose cartilage has deteriorated locally.
The ChondroFiller® was designed to address this problem: to specifically fill in cartilage loss, by providing a structure that supports cell regrowth. This is a treatment minimally invasive, biological and absorbable, which allows for early intervention in the degenerative process, before a total prosthesis becomes necessary.
What is ChondroFiller® and how does it work?
The ChondroFiller® is a highly purified collagen matrix, Designed to mimic the natural structure of cartilage and promote tissue repair, this biomaterial acts as a "biological scaffold": once applied to the damaged area, it attracts the body's repair cells (including mesenchymal stem cells) and helps them to attach, proliferate, and then rebuild a replacement cartilage tissue.
The major advantage of ChondroFiller® is that it requires neither laboratory cell culture nor complex sampling. It is used in one step, This is done during arthroscopy, reducing costs, time, and risks. The matrix is completely resorbable: it gradually breaks down as new tissue forms. This process respects the patient's natural biology and allows for a harmonious integration in the joint environment.
Who is this innovative treatment intended for?
ChondroFiller® is indicated in patients with localized cartilage lesion, This treatment is for well-defined areas of pain, whether traumatic or degenerative in origin. It is primarily intended for young or middle-aged individuals who are still active and suffer from joint pain without generalized osteoarthritis. It can be used on the knee (femoral condyle, trochlea, patella), hip, or even ankle.
This treatment is particularly useful when discomfort persists despite well-conducted rehabilitation, hyaluronic acid injections, or PRP injections. It is indicated if imaging (MRI, CT arthrography) reveals a well-localized loss of cartilage tissue, without major joint deformity.
The main indications include:
- Isolated cartilage lesion, traumatic or degenerative
- Early-stage osteoarthritis limited to one compartment
- Chronic pain despite conservative treatment
- The goal is to delay prosthetic surgery.
On the other hand, ChondroFiller® is not suitable for cases of advanced osteoarthritis, with diffuse destruction of cartilage or significant joint instability.
How does the surgical procedure take place?
The application of ChondroFiller® is done during a arthroscopy, This is a minimally invasive surgical procedure. The patient is usually hospitalized for one day or one night. The operation begins with an exploration of the joint using a camera inserted through small incisions. The surgeon locates the lesion, cleans it carefully, and then prepares the area to receive the biomaterial.
ChondroFiller® is then injected or applied as a gel or membrane directly into the cartilage cavity. Thanks to its adhesive and cohesive properties, it remains in place without the need for sutures. Once the matrix is positioned, the joint is closed and a postoperative recovery protocol is implemented.
What are the post-operative and expected recovery steps?
Recovery after treatment with ChondroFiller® depends on the location and size of the lesion. Generally, a period of partial or total discharge is recommended for a period of a few days to a few weeks, in order not to disrupt the fixation of the biomaterial. The gradual return to weight-bearing is accompanied by a personalized rehabilitation, focused on joint mobility, muscle strengthening and proprioception.
Pain usually decreases within the first few weeks. The beneficial effects of the treatment are often visible between [dates missing] 6 and 12 weeks Following the procedure, function will gradually improve. A return to gentle sports activities is possible from the third month, while more intense sports (jumping, pivoting, running) often require a delay of 4 to 6 months. Patience is essential, as the cartilage repair process is slow but progressive.
What long-term results can we expect?
The ChondroFiller® allows a functional cartilage repair, This means that a replacement tissue forms, capable of withstanding the mechanical stresses of daily life. Although this new cartilage is not identical to the original cartilage, it can significantly reduce pain, improve mobility And postpone the need for prosthetic surgery.
The benefits reported in the specialized literature are as follows:
- Significant reduction or disappearance of mechanical pain
- Gradual recovery of joint range of motion
- Resumption of sporting or professional activities
- Preservation of the joint over several years
In some cases, ChondroFiller® is combined with injections of PRP or stem cells, in order to boost the regenerative process. The approach always remains personalized, depending on the type of lesion, the patient's condition and their functional objectives.
A turning point in the conservative management of joints
The ChondroFiller® illustrates the current evolution of orthopedic surgery towards solutions Less invasive, more biological, and better tolerated., which aim to preserve the joint rather than replace it. It offers a concrete answer to a frequent but still poorly managed problem: focal cartilage lesions in patients too young for a prosthesis, but too symptomatic for simple conservative treatment.
Thanks to this technology, it is now possible to repair cartilage before wear and tear becomes irreversible. This not only relieves pain and improves joint function, but also... maintain a satisfactory level of activity for several years.
